Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Procept Biorobotics Corp (PRCT)

Procept Biorobotics Corp (PRCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,338,477
  • Shares Outstanding, K 54,819
  • Annual Sales, $ 224,500 K
  • Annual Income, $ -91,410 K
  • EBIT $ -97 M
  • EBITDA $ -91 M
  • 60-Month Beta 1.05
  • Price/Sales 14.19
  • Price/Cash Flow N/A
  • Price/Book 7.54

Options Overview Details

View History
  • Implied Volatility 59.30% ( +1.25%)
  • Historical Volatility 59.61%
  • IV Percentile 48%
  • IV Rank 14.52%
  • IV High 147.70% on 07/29/24
  • IV Low 44.28% on 05/24/24
  • Put/Call Vol Ratio 0.21
  • Today's Volume 318
  • Volume Avg (30-Day) 561
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 6,838
  • Open Int (30-Day) 10,797

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.49
  • Number of Estimates 8
  • High Estimate -0.47
  • Low Estimate -0.51
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +3.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.14 +13.40%
on 03/13/25
70.80 -11.68%
on 02/26/25
-0.18 (-0.29%)
since 02/25/25
3-Month
55.14 +13.40%
on 03/13/25
89.49 -30.13%
on 01/06/25
-21.19 (-25.31%)
since 12/24/24
52-Week
45.56 +37.25%
on 04/04/24
103.81 -39.76%
on 11/11/24
+15.52 (+33.01%)
since 03/25/24

Most Recent Stories

More News
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

PRCT : 62.53 (+2.68%)
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

PRCT : 62.53 (+2.68%)
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

PRCT : 62.53 (+2.68%)
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

PRCT : 62.53 (+2.68%)
Insider Sale: President of $PRCT (PRCT) Sells 18,144 Shares

Reza Zadno, the President of $PRCT ($PRCT), sold 18,144 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 8.8% of their shares....

PRCT : 62.53 (+2.68%)
PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

PRCT : 62.53 (+2.68%)
PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

PRCT : 62.53 (+2.68%)
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

PRCT : 62.53 (+2.68%)
PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

PRCT : 62.53 (+2.68%)
PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

PRCT : 62.53 (+2.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use...

See More

Key Turning Points

3rd Resistance Point 69.23
2nd Resistance Point 66.80
1st Resistance Point 64.67
Last Price 62.53
1st Support Level 60.11
2nd Support Level 57.68
3rd Support Level 55.55

See More

52-Week High 103.81
Fibonacci 61.8% 81.56
Fibonacci 50% 74.68
Fibonacci 38.2% 67.81
Last Price 62.53
52-Week Low 45.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar